Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,233) with videos related to
Page
of 124
Sort By:
Science Advances
|
June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy
Gonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Human Vaccines & Immunotherapeutics
|
May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events
Claudia Schmidt, Carol Smith, Burc Barin, et al.
Nucleic Acids Research
|
December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy
Eeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Journal of Medicinal Chemistry
|
January 8, 2016
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
Timothy P Heffron, Robert A Heald, Chudi Ndubaku, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2013
Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform
Steven T Staben, Chudi Ndubaku, Nicole Blaquiere, et al.
Frontiers in Medicine
|
July 2, 2024
Changes in primary care visits for respiratory illness during the COVID-19 pandemic: a multinational study by the International Consortium of Primary Care Big Data Researchers (INTRePID)
John M Westfall, Angela Ortigoza Bonilla, María C Lapadula, et al.
Journal of Medicinal Chemistry
|
May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors
James W Leahy, Chris A Buhr, Henry W B Johnson, et al.
The American Journal of Gastroenterology
|
January 6, 2016
Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium
Melyssa Aronson, Steven Gallinger, Zane Cohen, et al.
Journal of Medicinal Chemistry
|
December 8, 2025
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1
Sam E Mann, Owen A Davis, Jörg Bomke, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor
Bryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Page
of 124
Search research articles
Search
Showing results (1201-1210 of 1,233) with videos related to
Sort By:
Page
of 124
Science Advances
|
June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy
Gonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Human Vaccines & Immunotherapeutics
|
May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events
Claudia Schmidt, Carol Smith, Burc Barin, et al.
Nucleic Acids Research
|
December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy
Eeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Journal of Medicinal Chemistry
|
January 8, 2016
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
Timothy P Heffron, Robert A Heald, Chudi Ndubaku, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2013
Discovery of thiazolobenzoxepin PI3-kinase inhibitors that spare the PI3-kinase β isoform
Steven T Staben, Chudi Ndubaku, Nicole Blaquiere, et al.
Frontiers in Medicine
|
July 2, 2024
Changes in primary care visits for respiratory illness during the COVID-19 pandemic: a multinational study by the International Consortium of Primary Care Big Data Researchers (INTRePID)
John M Westfall, Angela Ortigoza Bonilla, María C Lapadula, et al.
Journal of Medicinal Chemistry
|
May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors
James W Leahy, Chris A Buhr, Henry W B Johnson, et al.
The American Journal of Gastroenterology
|
January 6, 2016
Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium
Melyssa Aronson, Steven Gallinger, Zane Cohen, et al.
Journal of Medicinal Chemistry
|
December 8, 2025
Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1
Sam E Mann, Owen A Davis, Jörg Bomke, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor
Bryan K Chan, Emily J Hanan, Krista K Bowman, et al.
Page
of 124